Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


Articles published in Urol Int

Retrieve available abstracts of 49 articles:
HTML format
Text format



Single Articles


    April 2017
  1. CHOI H, Cho S, Bae JH, Lee SE, et al
    Characteristics of Prostate Cancer by Opportunistic Screening in Korean Men with a Prostate-Specific Antigen Level Less Than 4.0 ng per Milliliter.
    Urol Int. 2017 Apr 11. doi: 10.1159/000454886.
    PubMed     Text format     Abstract available


    March 2017
  2. PORCARO AB, de Luyk N, Corsi P, Sebben M, et al
    Clinical Factors Predicting and Stratifying the Risk of Lymph Node Invasion in Localized Prostate Cancer.
    Urol Int. 2017 Mar 1. doi: 10.1159/000458763.
    PubMed     Text format     Abstract available


  3. PORCARO AB, De Luyk N, Corsi P, Sebben M, et al
    Association between Basal Total Testosterone Levels and Tumor Upgrading in Low and Intermediate Risk Prostate Cancer.
    Urol Int. 2017 Mar 1. doi: 10.1159/000459632.
    PubMed     Text format     Abstract available


    February 2017
  4. SAKAI Y, Komai Y, Saito N, Ito M, et al
    Analysis of a Surgical Treatment for Persistent Urorectal Fistulas after Radical Cancer Surgery: A Comparison of Prostate Cancer and Rectal Cancer.
    Urol Int. 2017 Feb 24. doi: 10.1159/000457835.
    PubMed     Text format     Abstract available


  5. LEAO R, Domingos C, Figueiredo A, Hamilton R, et al
    Cancer Stem Cells in Prostate Cancer: Implications for Targeted Therapy.
    Urol Int. 2017 Feb 1. doi: 10.1159/000455160.
    PubMed     Text format     Abstract available


    January 2017
  6. POELAERT F, Kumps C, Lumen N, Verschuere S, et al
    Androgen Receptor Gene Copy Number and Protein Expression in Treatment-Naive Prostate Cancer.
    Urol Int. 2017 Jan 5. doi: 10.1159/000455158.
    PubMed     Text format     Abstract available


  7. ORBERGER M, Palisaar J, Roghmann F, Mittelstadt L, et al
    Association between the Surgical Apgar Score and Perioperative Complications after Radical Prostatectomy.
    Urol Int. 2017;98:61-70.
    PubMed     Text format     Abstract available


  8. KLEIN J, de Gorski A, Benamran D, Vallee JP, et al
    Transrectal Ultrasound-Guided Prostate Biopsy for Cancer Detection: Performance of 2D-, 3D- and 3D-MRI Fusion Targeted Techniques.
    Urol Int. 2017;98:7-14.
    PubMed     Text format     Abstract available


  9. HAAS M, Gunzel K, Miller K, Hamm B, et al
    Is the Ellipsoid Formula the New Standard for 3-Tesla MRI Prostate Volume Calculation without Endorectal Coil?
    Urol Int. 2017;98:49-53.
    PubMed     Text format     Abstract available


  10. GUNZEL K, Haas M, Maxeiner A, Stephan C, et al
    Predictive Parameters Identifying Men Eligible for a Sole MRI/Ultrasound Fusion-Guided Targeted Biopsy without an Additional Systematic Biopsy.
    Urol Int. 2017;98:15-21.
    PubMed     Text format     Abstract available


  11. SCHIFFMANN J, Larcher A, Sun M, Tian Z, et al
    Differences in Patient Characteristics among Men Choosing Open or Robot-Assisted Radical Prostatectomy in Contemporary Practice - Analysis of Surveillance, Epidemiology, and End Results Database.
    Urol Int. 2017;98:40-48.
    PubMed     Text format     Abstract available


  12. MENDEZ-RUBIO S, Salinas Casado J, Virseda Chamorro M, Gutierrez Martin P, et al
    Post Pelvic Radiotherapy Affectation of the Lower Urinary Tract Peripheral Innervation in Men.
    Urol Int. 2017;98:85-88.
    PubMed     Text format     Abstract available


    November 2016
  13. PORCARO AB, Cavicchioli F, Mattevi D, De Luyk N, et al
    Clinical Factors of Disease Reclassification or Progression in a Contemporary Cohort of Prostate Cancer Patients Elected to Active Surveillance.
    Urol Int. 2016.
    PubMed     Text format     Abstract available


    September 2016
  14. ZHU W, Xu H, Ma J, Guo J, et al
    An Open-Label Pilot Study of Metformin as a Concomitant Therapy on Patients with Prostate Cancer Undergoing Androgen Deprivation Treatment.
    Urol Int. 2016.
    PubMed     Text format     Abstract available


    July 2016
  15. MORAN PASCUAL E, Martinez Sarmiento M, Budia Alba A, Broseta Rico E, et al
    Central Body Fat Mass Measured by Bioelectrical Impedanciometry But Not Body Mass Index Is a High-Grade Prostate Cancer Risk Factor.
    Urol Int. 2016.
    PubMed     Text format     Abstract available


  16. PORCARO AB, Novella G, Cacciamani G, De Marchi D, et al
    Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set.
    Urol Int. 2016.
    PubMed     Text format     Abstract available


    June 2016
  17. ODERDA M, Faletti R, Battisti G, Dalmasso E, et al
    Prostate Cancer Detection Rate with Koelis Fusion Biopsies versus Cognitive Biopsies: A Comparative Study.
    Urol Int. 2016.
    PubMed     Text format     Abstract available


    April 2016
  18. ZHENG Y, Zhu C, Ma L, Shao P, et al
    miRNA-154-5p Inhibits Proliferation, Migration and Invasion by Targeting E2F5 in Prostate Cancer Cell Lines.
    Urol Int. 2016.
    PubMed     Text format     Abstract available


  19. ALMEIDA GL, Petralia G, Ferro M, Ribas CA, et al
    Role of Multi-Parametric Magnetic Resonance Image and PIRADS Score in Patients with Prostate Cancer Eligible for Active Surveillance According PRIAS Criteria.
    Urol Int. 2016.
    PubMed     Text format     Abstract available


    March 2016
  20. WEISS M, Ahrend H, Grossebrummel H, Ziegler P, et al
    Cytochrome P450 17A1 Inhibitor Abiraterone Acetate Counteracts the Heat Shock Protein 27's Cell Survival Properties in Prostate Cancer Cells.
    Urol Int. 2016.
    PubMed     Text format     Abstract available


  21. PORCARO AB, Siracusano S, De Luyk N, Corsi P, et al
    Low-Risk Prostate Cancer and Tumor Upgrading to Higher Patterns in the Surgical Specimen. Analysis of Clinical Factors Predicting Tumor Upgrading to Higher Gleason Patterns in a Contemporary Series of Patients Who Have Been Evaluated According to the
    Urol Int. 2016.
    PubMed     Text format     Abstract available


    February 2016
  22. WANG J, Cheng G, Li X, Huang Y, et al
    Developing a Correct System to Evaluate the Accuracy of Gleason Score in Prostate Cancer of Chinese Population.
    Urol Int. 2016.
    PubMed     Text format     Abstract available


  23. PORCARO AB, Petroziello A, Brunelli M, De Luyk N, et al
    High Testosterone Preoperative Plasma Levels Independently Predict Biopsy Gleason Score Upgrading in Men with Prostate Cancer Undergoing Radical Prostatectomy.
    Urol Int. 2016.
    PubMed     Text format     Abstract available


    January 2016
  24. GAKIS G, Rink M, Fritsche HM, Graefen M, et al
    Prognostic Significance of Incidental Prostate Cancer at Radical Cystoprostatectomy for Bladder Cancer.
    Urol Int. 2016.
    PubMed     Text format     Abstract available


  25. ALCHIN DR, Murphy D, Lawrentschuk N
    What Are the Predictive Factors for Gleason Score Upgrade following RP?
    Urol Int. 2016;96:1-4.
    PubMed     Text format     Abstract available


  26. MARTORANA E, Ghaith A, Micali S, Pirola GM, et al
    A Retrospective Analysis of the Hemostatic Effect of FloSeal in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy.
    Urol Int. 2016;96:274-9.
    PubMed     Text format     Abstract available


  27. YAMADA Y, Fujimura T, Fukuhara H, Miyagawa J, et al
    Measuring Contact Pressure of Lower Extremities in Patients Undergoing Robot-Assisted Radical Prostatectomy.
    Urol Int. 2016;96:268-73.
    PubMed     Text format     Abstract available


  28. BIER S, Hennenlotter J, Rausch S, Aufderklamm S, et al
    Return to Work and Normal Daily Life Activity after Open and Robot-Assisted Radical Prostatectomy--A Single Surgeon Analysis.
    Urol Int. 2016;96:280-6.
    PubMed     Text format     Abstract available


  29. FROEHNER M, Propping S, Koch R, Borkowetz A, et al
    Is the Post-Radical Prostatectomy Gleason Score a Valid Predictor of Mortality after Neoadjuvant Hormonal Treatment?
    Urol Int. 2016;96:302-8.
    PubMed     Text format     Abstract available


  30. NIKLAS C, Saar M, Berg B, Steiner K, et al
    da Vinci and Open Radical Prostatectomy: Comparison of Clinical Outcomes and Analysis of Insurance Costs.
    Urol Int. 2016;96:287-94.
    PubMed     Text format     Abstract available


  31. SARKAR D, Ekwueme K, Parr N
    Patient-Reported Experience of Modified Transperineal Template Guided Saturation Biopsy Under General Anaesthesia and without Prophylactic Catheterisation.
    Urol Int. 2016;96:479-83.
    PubMed     Text format     Abstract available


  32. ANGULO JC, Lopez JI, Dorado JF, Sanchez-Chapado M, et al
    A DNA Hypermethylation Profile Independently Predicts Biochemical Recurrence Following Radical Prostatectomy.
    Urol Int. 2016;97:16-25.
    PubMed     Text format     Abstract available


  33. ROSENKRANTZ AB, Lepor H, Huang WC, Taneja SS, et al
    Practical Barriers to Obtaining Pre-Biopsy Prostate MRI: Assessment in Over 1,500 Consecutive Men Undergoing Prostate Biopsy in a Single Urologic Practice.
    Urol Int. 2016;97:247-8.
    PubMed     Text format    


  34. SCHIFFMANN J, Haese A, Lenz J, Heinzer H, et al
    Differences in Patient Characteristics Among Men Choosing Open or Robot-Assisted Radical Prostatectomy in Contemporary Practice at a European High-Volume Center.
    Urol Int. 2016;97:8-15.
    PubMed     Text format     Abstract available


    December 2015
  35. MAEDA Y, Kawahara T, Kumano Y, Ohtaka M, et al
    The Neutrophil-to-Lymphocyte Ratio before Repeat Prostate Needle Biopsy for Predicting Prostate Cancer.
    Urol Int. 2015.
    PubMed     Text format    


  36. UMBEHR MH, Luscher M, Hunziker R, Falkner F, et al
    Influence of Varying Assessment Parameters on the Diagnostic Accuracy of Magnetic Resonance Imaging in the Local Staging of Prostate Cancer.
    Urol Int. 2015.
    PubMed     Text format     Abstract available


  37. OZEL D, Duran Ozel B, Ozkan F
    Viscosity as a Biomarker Coincident with Shear Wave Elastography. Re: Prediction of Significant Prostate Cancer at Prostate Biopsy and Per Core Detection Rate of Targeted and Systematic Biopsies Using Real-Time Shear Wave Elastography (Urol Int 2015;
    Urol Int. 2015.
    PubMed     Text format    


    November 2015
  38. BUTOW Z, Schunk S, Janssen M, Graber S, et al
    Quality of Preoperative Biopsy Is a Risk Factor for Positive Surgical Margins in Organ-Confined Prostate Cancer Treated with Nerve-Sparing Robot-Assisted Radical Prostatectomy.
    Urol Int. 2015.
    PubMed     Text format     Abstract available


  39. RICHTERS A, Derks J, Fossion LM, Kil PJ, et al
    Presence and Number of Positive Surgical Margins after Radical Prostatectomy for Prostate Cancer: Effect on Oncological Outcome in a Population-Based Cohort.
    Urol Int. 2015.
    PubMed     Text format     Abstract available


    October 2015
  40. SENZAKI T, Fukumori T, Mori H, Kusuhara Y, et al
    Clinical Significance of Neoadjuvant Combined Androgen Blockade for More Than Six Months in Patients with Localized Prostate Cancer Treated with Prostate Brachytherapy.
    Urol Int. 2015.
    PubMed     Text format     Abstract available


  41. SOGA N, Yatabe Y, Kageyama T, Ogura Y, et al
    Review of Bioptic Gleason Scores by Central Pathologist Modifies the Risk Classification in Prostate Cancer.
    Urol Int. 2015.
    PubMed     Text format     Abstract available


    July 2015
  42. ALLAN C, Ilic D
    Laparoscopic versus Robotic-Assisted Radical Prostatectomy for the Treatment of Localised Prostate Cancer: A Systematic Review.
    Urol Int. 2015.
    PubMed     Text format     Abstract available


  43. CAPOUN O, Soukup V, Kalousova M, Sobotka R, et al
    Diagnostic Importance of Selected Protein Serum Markers in the Primary Diagnostics of Prostate Cancer.
    Urol Int. 2015.
    PubMed     Text format     Abstract available


  44. WINTER A, Kneib T, Rohde M, Henke RP, et al
    First Nomogram Predicting the Probability of Lymph Node Involvement in Prostate Cancer Patients Undergoing Radioisotope Guided Sentinel Lymph Node Dissection.
    Urol Int. 2015.
    PubMed     Text format     Abstract available


    June 2015
  45. XU G, Yao M, Wu J, Guo L, et al
    Diagnostic Value of Different Systematic Prostate Biopsy Methods in the Detection of Prostate Cancer with Ultrasonographic Hypoechoic Lesions - A Comparative Study.
    Urol Int. 2015.
    PubMed     Text format     Abstract available


  46. BOEHM K, Budaus L, Tennstedt P, Beyer B, et al
    Prediction of Significant Prostate Cancer at Prostate Biopsy and Per Core Detection Rate of Targeted and Systematic Biopsies Using Real-Time Shear Wave Elastography.
    Urol Int. 2015.
    PubMed     Text format     Abstract available


    May 2015
  47. HERDEN J, Eminaga O, Wille S, Weissbach L, et al
    Treatment of Incidental Prostate Cancer by Active Surveillance: Results of the HAROW Study.
    Urol Int. 2015.
    PubMed     Text format     Abstract available


    January 2015
  48. GEIGER-GRITSCH S, Oberaigner W, Muhlberger N, Siebert U, et al
    Patient-Reported Urinary Incontinence and Erectile Dysfunction Following Radical Prostatectomy: Results from the European Prostate Centre Innsbruck.
    Urol Int. 2015.
    PubMed     Text format     Abstract available


  49. MATEI DV, Ferro M, Jereczek-Fossa BA, Renne G, et al
    Salvage radical prostatectomy after external beam radiation therapy: a systematic review of current approaches.
    Urol Int. 2015;94:373-82.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: